These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Preterm labor: approach to decreasing complications of prematurity. Locatelli A; Consonni S; Ghidini A Obstet Gynecol Clin North Am; 2015 Jun; 42(2):255-74. PubMed ID: 26002165 [TBL] [Abstract][Full Text] [Related]
6. Nonreceipt of antenatal magnesium sulphate for fetal neuroprotection at the Women's and Children's Hospital, Adelaide 2010-2013. Siwicki K; Bain E; Bubner T; Ashwood P; Middleton P; Crowther CA Aust N Z J Obstet Gynaecol; 2015 Jun; 55(3):233-8. PubMed ID: 26084194 [TBL] [Abstract][Full Text] [Related]
7. Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals. Bousleiman SZ; Rice MM; Moss J; Todd A; Rincon M; Mallett G; Milluzzi C; Allard D; Dorman K; Ortiz F; Johnson F; Reed P; Tolivaisa S; Am J Obstet Gynecol; 2015 Sep; 213(3):398.e1-11. PubMed ID: 25957021 [TBL] [Abstract][Full Text] [Related]
8. Preterm Labor: A Comprehensive Review of Guidelines on Diagnosis, Management, Prediction and Prevention. Giouleka S; Tsakiridis I; Kostakis N; Koutsouki G; Kalogiannidis I; Mamopoulos A; Athanasiadis A; Dagklis T Obstet Gynecol Surv; 2022 May; 77(5):302-317. PubMed ID: 35522432 [TBL] [Abstract][Full Text] [Related]
9. Survey on use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth in Australia and New Zealand - Ongoing barriers and enablers. Gatman K; May R; Crowther C Aust N Z J Obstet Gynaecol; 2020 Feb; 60(1):44-48. PubMed ID: 31119725 [TBL] [Abstract][Full Text] [Related]
10. Committee Opinion No 652: Magnesium Sulfate Use in Obstetrics. Obstet Gynecol; 2016 Jan; 127(1):e52-e53. PubMed ID: 26695587 [TBL] [Abstract][Full Text] [Related]
11. [Prevention of preterm birth complications by antenatal corticosteroid administration]. Schmitz T J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1399-1417. PubMed ID: 27776846 [TBL] [Abstract][Full Text] [Related]
13. [Prevention of spontaneous preterm birth (excluding preterm premature rupture of membranes): Guidelines for clinical practice - Text of the Guidelines (short text)]. Sentilhes L; Sénat MV; Ancel PY; Azria E; Benoist G; Blanc J; Brabant G; Bretelle F; Brun S; Doret M; Ducroux-Schouwey C; Evrard A; Kayem G; Maisonneuve E; Marcellin L; Marret S; Mottet N; Paysant S; Riethmuller D; Rozenberg P; Schmitz T; Torchin H; Langer B J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1446-1456. PubMed ID: 27836377 [TBL] [Abstract][Full Text] [Related]
14. Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health. Vogel JP; Souza JP; Gülmezoglu AM; Mori R; Lumbiganon P; Qureshi Z; Carroli G; Laopaiboon M; Fawole B; Ganchimeg T; Zhang J; Torloni MR; Bohren M; Temmerman M; Lancet; 2014 Nov; 384(9957):1869-1877. PubMed ID: 25128271 [TBL] [Abstract][Full Text] [Related]
16. Antenatal corticosteroids in the management of preterm birth: are we back where we started? Bonanno C; Wapner RJ Obstet Gynecol Clin North Am; 2012 Mar; 39(1):47-63. PubMed ID: 22370107 [TBL] [Abstract][Full Text] [Related]